PRKAA2 and colorectal cancer: To further investigate whether elevated basal AMPK activity generates an intracellular signalling context that renders cells more sensitive to metformin, we treated two genetically diverse colorectal cancer cell lines with the specific AMPK activator A-769662 for 24 h before adding metformin.